These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11605931)

  • 1. Effects of rapacuronium on respiratory function during general anesthesia: a comparison with cis-atracurium.
    Tobias JD; Johnson JO; Sprague K; Johnson G
    Anesthesiology; 2001 Oct; 95(4):908-12. PubMed ID: 11605931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect on lung mechanics in anesthetized children with rapacuronium: a comparative study with mivacurium.
    Fine GF; Motoyama EK; Brandom BW; Fertal KM; Mutich R; Davis PJ
    Anesth Analg; 2002 Jul; 95(1):56-61, table of contents. PubMed ID: 12088943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intubating conditions after rapacuronium (Org 9487) and succinylcholine following rapid sequence induction in adult patients.
    Sparr HJ; Mellinghoff H; Blobner M; Nöldge-Schomburg G
    Br J Anaesth; 1999 Apr; 82(4):537-41. PubMed ID: 10472218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the intubation conditions provided by rapacuronium (ORG 9487) or succinylcholine in humans during anesthesia with fentanyl and propofol.
    Fleming NW; Chung F; Glass PS; Kitts JB; Kirkegaard-Nielsen H; Gronert GA; Chan V; Gan TJ; Cicutti N; Caldwell JE
    Anesthesiology; 1999 Nov; 91(5):1311-7. PubMed ID: 10551582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the choice of intravenous induction drug affect intubation conditions after a fast-onset neuromuscular blocker?
    El-Orbany MI; Wafai Y; Joseph NJ; Salem MR
    J Clin Anesth; 2003 Feb; 15(1):9-14. PubMed ID: 12657404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1.
    Blobner M; Mirakhur RK; Wierda JM; Wright PM; Olkkola KT; Debaene B; Pendeville P; Engbaek J; Rietbergen H; Sparr HJ
    Br J Anaesth; 2000 Nov; 85(5):724-31. PubMed ID: 11094588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atracurium versus vecuronium in asthmatic patients. A blinded, randomized comparison of adverse events.
    Caldwell JE; Lau M; Fisher DM
    Anesthesiology; 1995 Nov; 83(5):986-91. PubMed ID: 7486185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of rapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia.
    Levy JH; Pitts M; Thanopoulos A; Szlam F; Bastian R; Kim J
    Anesth Analg; 1999 Aug; 89(2):290-5. PubMed ID: 10439732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-ranging study of rapacuronium in pediatric patients.
    Meakin GH; Meretoja OA; Motsch J; Taivainen T; Wirtavuori K; Schönstedt R; Perkins R; McCluskey A
    Anesthesiology; 2000 Apr; 92(4):1002-9. PubMed ID: 10754619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potency (ED50) and cardiovascular effects of rapacuronium (Org 9487) during narcotic-nitrous oxide-propofol anesthesia in neonates, infants, and children.
    Kaplan RF; Fletcher JE; Hannallah RS; Bui DT; Slaven JS; Darrow EJ; Tsai KT
    Anesth Analg; 1999 Nov; 89(5):1172-6. PubMed ID: 10553829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.
    Jooste E; Klafter F; Hirshman CA; Emala CW
    Anesthesiology; 2003 Apr; 98(4):906-11. PubMed ID: 12657852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapacuronium: clinical pharmacology.
    Mirakhur RK; McCourt KC
    Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The time-course of action of rapacuronium and mivacurium after early reversal following equally lasting relaxation].
    Geldner G; Lang C; Hoffmann W; Hossfeld A; Weinberger J; Eble M; Blobner M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):594-9. PubMed ID: 12975739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response and onset/offset characteristics of rapacuronium.
    Kopman AF; Klewicka MM; Ghori K; Flores F; Neuman GG
    Anesthesiology; 2000 Oct; 93(4):1017-21. PubMed ID: 11020757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrhosis.
    Duvaldestin P; Slavov V; Rebufat Y
    Anesthesiology; 1999 Nov; 91(5):1305-10. PubMed ID: 10551581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholine.
    Miguel R; Witkowski T; Nagashima H; Fragen R; Bartkowski R; Foldes FF; Shanks C
    Anesthesiology; 1999 Dec; 91(6):1648-54. PubMed ID: 10598606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
    Wight WJ; Wright PM
    Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapacuronium: a new, non-depolarizing muscle relaxant for rapid intubation?].
    Busley R; Blobner M; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Feb; 35(2):112-4. PubMed ID: 10719607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.